Operation Warp Speed (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Operation Warp Speed" in English language version.

refsWebsite

Global rank English rank

70web.archive.org

1^st place

11nytimes.com

7^th place

10nih.gov

4^th place

9worldcat.org

5^th place

7hhs.gov

5,973^rd place

3,693^rd place

7cnbc.com

220^th place

155^th place

7cnn.com

28^th place

26^th place

6doi.org

2^nd place

4bloomberg.com

99^th place

77^th place

4defense.gov

1,038^th place

668^th place

3washingtonpost.com

34^th place

27^th place

3reuters.com

49^th place

47^th place

2semanticscholar.org

11^th place

8^th place

2esquire.com

472^nd place

340^th place

2newsweek.com

269^th place

201^st place

2genengnews.com

low place

6,625^th place

2politico.com

312^th place

197^th place

2fda.gov

447^th place

338^th place

2wbur.org

2,911^th place

1,596^th place

2cdc.gov

218^th place

212^th place

2biontech.de

low place

1science.org

1,160^th place

737^th place

1archive.today

14^th place

1usatoday.com

41^st place

34^th place

1npr.org

92^nd place

72^nd place

1harvard.edu

18^th place

17^th place

1nymag.com

346^th place

229^th place

1ama-assn.org

3,257^th place

3,398^th place

1marketplace.org

low place

6,795^th place

1army.mil

249^th place

169^th place

1ndia.org

low place

1digitech-insight.com

low place

1prweb.com

3,093^rd place

1,787^th place

1govconwire.com

low place

1bbc.co.uk

8^th place

10^th place

1fiercebiotech.com

low place

8,828^th place

1novavax.com

low place

1statnews.com

8,771^st place

5,253^rd place

1fiercepharma.com

low place

8,921^st place

1axios.com

1,716^th place

973^rd place

1yahoo.com

38^th place

40^th place

1nbcnews.com

137^th place

101^st place

1gao.gov

2,954^th place

1,848^th place

1time.com

61^st place

54^th place

1forbes.com

54^th place

48^th place

1pfizer.com

low place

1politifact.com

3,208^th place

1,803^rd place

1archives.gov

446^th place

308^th place

1who.int

195^th place

302^nd place

1pewresearch.org

1,418^th place

966^th place

1medcitynews.com

low place

1stanford.edu

179^th place

183^rd place

ama-assn.org (Global: 3,257^th place; English: 3,398^th place)

"AMA, FDA video update: The critical role of health care professionals during COVID-19". AMA-Assn.org. American Medical Association. August 14, 2020. Archived from the original on December 18, 2020. Retrieved December 17, 2020.

archive.today (Global: 14^th place; English: 14^th place)

ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES (ACTIV)

archives.gov (Global: 446^th place; English: 308^th place)

trumpwhitehouse.archives.gov

Trump, Donald. "Executive Order on Ensuring Access to United States Government COVID-19 Vaccines". whitehouse.gov. Archived from the original on January 20, 2021. Retrieved December 12, 2020 – via National Archives.

army.mil (Global: 249^th place; English: 169^th place)

eis.army.mil

Guckert, Ross (June 4, 2020). "PEO Perspective: June 2020". PEO EIS. Archived from the original on December 20, 2020. Retrieved December 8, 2020.

axios.com (Global: 1,716^th place; English: 973^rd place)

Axios (November 9, 2020). "Pfizer CEO says he would've released vaccine data before election if possible". Axios. Archived from the original on December 10, 2020. Retrieved November 11, 2020.

bbc.co.uk (Global: 8^th place; English: 10^th place)

"Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK". BBC News Online. December 30, 2020. Retrieved March 24, 2020.

biontech.de (Global: low place; English: low place)

biontech.de

"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Archived from the original on December 18, 2020. Retrieved December 13, 2020.

investors.biontech.de

"BioNTech erhält BMBF-Förderung von bis zu 375 Millionen Euro für COVID-19-Impfstoffprogramm BNT162" [BioNTech receives BMBF funding of up to 375 million euros for COVID-19 vaccine program BNT162]. investors.biontech.de (in German). September 15, 2020. Retrieved August 30, 2021.

bloomberg.com (Global: 99^th place; English: 77^th place)

Jacobs, Jennifer; Armstrong, Drew (April 29, 2020). "Trump's 'Operation Warp Speed' aims to rush coronavirus vaccine". Bloomberg News. Archived from the original on December 17, 2020. Retrieved May 15, 2020.
Jacobs, Jennifer; Armstrong, Drew (April 29, 2020). "Trump's 'Operation Warp Speed' Aims to Rush Coronavirus Vaccine". Bloomberg News. Archived from the original on December 17, 2020. Retrieved May 15, 2020.
Stephanie Baker; Cynthia Koons (October 29, 2020). "Inside Operation Warp Speed's $18 Billion Sprint for a Vaccine". Bloomberg Businessweek. Archived from the original on December 8, 2020. Retrieved November 24, 2020.
Griffin, Riley; Armstrong, Drew (November 9, 2020). "Pfizer Vaccine's Funding Came From Berlin, Not Washington". Bloomberg News. Archived from the original on November 9, 2020. Retrieved February 8, 2024.

cdc.gov (Global: 218^th place; English: 212^th place)

cdc.gov

"Media Statement from CDC Director Rochelle P. Walensky, MD, MPH, on Signing the Advisory Committee on Immunization Practices' Recommendation to Use Janssen's COVID-19 Vaccine in People 18 and Older". Centers for Disease Control and Prevention (CDC) (Press release). February 28, 2021. Retrieved March 24, 2021.

covid.cdc.gov

"CDC COVID Data Tracker". March 28, 2020. Archived from the original on January 25, 2021. Retrieved January 6, 2021.

cnbc.com (Global: 220^th place; English: 155^th place)

Noah Higgins-Dunn (August 14, 2020). "The U.S. has already invested billions in potential coronavirus vaccines. Here's where the deals stand". CNBC. Archived from the original on December 8, 2020. Retrieved September 24, 2020.
Higgins-Dunn, Noah (August 5, 2020). "Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion". CNBC. Archived from the original on December 9, 2020. Retrieved November 19, 2020.
"Experimental Johnson & Johnson vaccine protects monkeys in a single dose, study finds". CNBC. Reuters. July 30, 2020. Archived from the original on October 25, 2020. Retrieved November 19, 2020.
Sam Meredith (March 15, 2021). "Germany, France, Spain and Italy become latest countries to suspend AstraZeneca vaccine over blood clot fears". CNBC. Retrieved March 24, 2020.
"Operation Warp Speed chief says Covid vaccine distribution 'should be better' as U.S. misses goal". CNBC. December 30, 2020. Archived from the original on January 4, 2021. Retrieved January 7, 2021.
Lovelace, Berkeley Jr. (November 18, 2020). "Watch live: U.S. officials speak on Operation Warp Speed after Pfizer releases positive vaccine data". CNBC. Retrieved July 1, 2021.
McKeever, Vicky (May 21, 2020). "AstraZeneca receives $1 billion in U.S. funding for Oxford University coronavirus vaccine". CNBC. Archived from the original on May 28, 2020. Retrieved May 28, 2020.

cnn.com (Global: 28^th place; English: 26^th place)

edition.cnn.com

Collins, Kaitlan; Diamond, Jeremy; Klein, Betsy (April 22, 2020). "Director of key federal vaccine agency says his departure was retaliation". CNN. Archived from the original on November 1, 2020. Retrieved August 30, 2020.
Hollingsworth, Julia (December 11, 2020). "GlaxoSmithKline and Sanofi Pasteur vaccine delayed until late 2021". CNN. Archived from the original on December 11, 2020. Retrieved December 11, 2020.
Dale, Daniel (November 10, 2020). "Fact-checking the battle for credit over Pfizer's vaccine announcement". CNN. Archived from the original on November 16, 2020. Retrieved February 8, 2024.
Gumbrecht, Jamie; Holmes, Kristen (December 23, 2020). "Trump administration to purchase additional 100 million Pfizer vaccine doses". CNN. Retrieved February 8, 2024.
Kristen Holmes; Sarah Mucha; Gregory Lemos (January 13, 2021). "Head of US vaccine effort resigns at request of incoming Biden administration but will stay through transition". CNN. Archived from the original on February 1, 2021. Retrieved January 30, 2021.

cnn.com

Maxouris, Christina (December 12, 2020). "FDA's Covid-19 vaccine authorization is a 'monumental moment,' expert says. It came on the deadliest day of the pandemic". CNN. Archived from the original on December 17, 2020. Retrieved December 12, 2020.
Christensen, Jen; Acosta, Jim; Carvajal, Nikki; Vazquez, Maegan (December 8, 2020). "Trump to sign order aimed at prioritizing Covid-19 vaccine shipment to Americans". CNN. Archived from the original on December 8, 2020. Retrieved December 8, 2020.

defense.gov (Global: 1,038^th place; English: 668^th place)

Vergun, David (February 25, 2021). "DOD Officials Provide COVID-19 Response Update". U.S. Department of Defense. Retrieved March 7, 2021.
C. Todd Lopez (October 28, 2020). "In Warp Speed Effort, Knowing Where Vaccines Are Is Key to Distribution Strategy". US Department of Defense. Archived from the original on December 5, 2020. Retrieved December 8, 2020.
Operation Warp Speed Official: First COVID-19 Vaccines to Arrive Monday Dec. 12, 2020 | By Terri Moon Cronk, DOD News. [1]
'Operation Warp Speed Official: First COVID-19 Vaccines to Arrive Monday.' Dec. 12, 2020 | By Terri Moon Cronk, DOD News. [2]

digitech-insight.com (Global: low place; English: low place)

Thorn, Amy. "Operation Warp Speed Raises Many Questions from The Supply Chain Industry Some with Answers That Have Yet to Emerge". DigiTech Insight. Retrieved July 21, 2021.

doi.org (Global: 2^nd place; English: 2^nd place)

Cohen, Jon (May 12, 2020). "Unveiling 'Warp Speed,' the White House's America-first push for a coronavirus vaccine". Science. doi:10.1126/science.abc7056. S2CID 219432336. Archived from the original on November 29, 2020. Retrieved May 16, 2020.
Cohen, Jon (January 29, 2021). "Ex-vaccine chief reflects on triumphs, failures, and Trump". Science. 371 (6528): 449–450. Bibcode:2021Sci...371..449C. doi:10.1126/science.371.6528.449. PMID 33510005.
Slaoui, Moncef; Hepburn, Matthew (August 26, 2020). "Developing safe and effective covid vaccines – Operation Warp Speed's strategy and approach". New England Journal of Medicine. 383 (18): 1701–1703. doi:10.1056/nejmp2027405. ISSN 0028-4793. PMID 32846056. S2CID 221347918. advancing eight vaccines in parallel will increase the chances of delivering 300 million doses in the first half of 2021 ... Of the eight vaccines in OWS's portfolio, six have been announced and partnerships executed with the companies: Moderna and Pfizer/BioNTech (both mRNA), AstraZeneca and Janssen (both replication-defective live-vector), and Novavax and Sanofi/GSK (both recombinant-subunit-adjuvanted protein). These candidates progressed to clinical trials.
Diamond, Michael S; Pierson, Theodore C (May 13, 2020). "The challenges of vaccine development against a new virus during a pandemic". Cell Host and Microbe. 27 (5): 699–703. doi:10.1016/j.chom.2020.04.021. PMC 7219397. PMID 32407708.
Kim, Jerome H; Hotez, Peter; Batista, Carolina; Ergonul, Onder; Figueroa, J Peter; Gilbert, Sarah; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Lall, Bhavna; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Shoham, Shmuel; Wilder-Smith, Annelies; Strub-Wourgaft, Nathalie; Yadav, Prashant; Bottazzi, Maria Elena (March 26, 2021). "Operation Warp Speed: implications for global vaccine security". The Lancet Global Health. 9 (7): e1017 – e1021. doi:10.1016/S2214-109X(21)00140-6. ISSN 2214-109X. PMC 7997645. PMID 33780663.
Dubé, Eve; Laberge, Caroline; Guay, Maryse; Bramadat, Paul; Roy, Réal; Bettinger, Julie (August 1, 2013). "Vaccine hesitancy: an overview". Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. ISSN 2164-554X. PMC 3906279. PMID 23584253.

esquire.com (Global: 472^nd place; English: 340^th place)

Inside the Messy Race to Develop a COVID Vaccine, Esquire (October 19, 2021).
"Inside the Messy Race to Develop a COVID Vaccine". esquire.com. October 19, 2021. Retrieved November 14, 2023.

fda.gov (Global: 447^th place; English: 338^th place)

"Pfizer-BioNTech COVID-19 Vaccine". US Food & Drug Administration (Press release). February 28, 2021. Archived from the original on December 12, 2020. Retrieved March 24, 2021.
"FDA Approves First COVID-19 Vaccine". Food and Drug Administration. August 23, 2021. Archived from the original on August 23, 2021. Retrieved May 25, 2025.

fiercebiotech.com (Global: low place; English: 8,828^th place)

Adams, Ben (July 27, 2020). "Moderna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test". FierceBiotech. Archived from the original on December 9, 2020. Retrieved November 20, 2020.

fiercepharma.com (Global: low place; English: 8,921^st place)

Angus Liu (July 31, 2020). "Top vaccine players Sanofi, GSK win $2.1B Warp Speed funding for COVID-19 shot". FiercePharma. Archived from the original on November 28, 2020. Retrieved September 24, 2020.

forbes.com (Global: 54^th place; English: 48^th place)

Jennings, Katie (November 17, 2020). "How Much Will A Covid-19 Vaccine Cost?". Forbes. Archived from the original on December 13, 2020. Retrieved December 6, 2020.

gao.gov (Global: 2,954^th place; English: 1,848^th place)

"Operation Warp Speed: Accelerated COVID-19 Vaccine Development Status and Efforts to Address Manufacturing Challenges". US Government Accountability Office. February 11, 2021. Retrieved May 6, 2022.

genengnews.com (Global: low place; English: 6,625^th place)

"Vaxart oral COVID-19 vaccine joins Trump's 'Warp Speed,' ramps up manufacturing capacity". Genetic Engineering and Biotechnology News. June 29, 2020. Archived from the original on September 29, 2020. Retrieved July 1, 2020.
"INOVIO Reports Positive Interim Phase I Data for COVID-19 DNA Vaccine, Joins 'Warp Speed' Primate Study". Genetic Engineering and Biotechnology News. June 30, 2020. Archived from the original on October 1, 2020. Retrieved July 1, 2020.

govconwire.com (Global: low place; English: low place)

Rivers, Brenda Marie (August 6, 2020). "Johnson & Johnson Secures $1B in Federal Vaccine Production Funding". GovCon Wire. Archived from the original on October 27, 2020. Retrieved November 19, 2020.

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

Cohen, Jon (January 29, 2021). "Ex-vaccine chief reflects on triumphs, failures, and Trump". Science. 371 (6528): 449–450. Bibcode:2021Sci...371..449C. doi:10.1126/science.371.6528.449. PMID 33510005.

hhs.gov (Global: 5,973^rd place; English: 3,693^rd place)

"Trump Administration Announces Framework and Leadership for 'Operation Warp Speed'". U.S. Department of Health and Human Services. May 15, 2020. Archived from the original on December 16, 2020. Retrieved May 15, 2020. Among its other objectives, Operation Warp Speed aims to have substantial quantities of a safe and effective vaccine available for Americans by January 2021.
"Fact Sheet: Explaining Operation Warp Speed". HHS.gov. US Department of Health and Human Services. November 10, 2020. Archived from the original on December 19, 2020. Retrieved November 24, 2020.
"HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses". HHS.gov. August 5, 2020. Archived from the original on December 12, 2020. Retrieved November 19, 2020.
"Trump Administration's Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October". HHS.gov (Press release). May 21, 2020. Archived from the original on December 20, 2020. Retrieved July 22, 2020.
"HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects". HHS.gov (Press release). July 6, 2020. Archived from the original on December 21, 2020. Retrieved December 20, 2020.
"HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment". HHS.gov (Press release). July 7, 2020. Archived from the original on December 18, 2020. Retrieved October 8, 2020.
"U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine". US Department of Health and Human Services. July 22, 2020. Archived from the original on December 17, 2020. Retrieved July 23, 2020.

marketplace.org (Global: low place; English: 6,795^th place)

Dan Gorenstein (October 30, 2014). "BARDA: The venture capital firm buried in the US government". Marketplace, Minnesota Public Radio. Archived from the original on June 13, 2020. Retrieved November 24, 2020.

medcitynews.com (Global: low place; English: low place)

Alaric Dearment (May 19, 2020). "Head of Trump's Covid-19 vaccine program to divest more than $10M in Moderna shares after criticism". MedCity News. Retrieved May 28, 2020.

nbcnews.com (Global: 137^th place; English: 101^st place)

"U.K. becomes first country to approve Pfizer-BioNTech Covid-19 vaccine". NBC News. December 2, 2020. Retrieved March 24, 2021.

ndia.org (Global: low place; English: low place)

"LTG Paul Ostrowski, USA (Ret)". National Defense Industrial Association. Archived from the original on December 20, 2020. Retrieved November 27, 2020.

newsweek.com (Global: 269^th place; English: 201^st place)

Crisp, Elizabeth (May 15, 2020). "Trump launches 'operation warp speed' effort to develop coronavirus vaccine by year's end". Newsweek. Archived from the original on May 19, 2020. Retrieved May 15, 2020. The project will cost billions of dollars, one of the people said. And it will almost certainly result in significant waste by making inoculations at scale before knowing if they'll be safe and effective – meaning that vaccines that fail will be useless. But it could mean having doses of vaccine available for the American public by the end of this year, instead of by next summer.
Czachor, Emily (November 9, 2020). "Pfizer Avoided R&D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics". Newsweek. Archived from the original on December 9, 2020. Retrieved November 9, 2020.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Cohen, Jon (January 29, 2021). "Ex-vaccine chief reflects on triumphs, failures, and Trump". Science. 371 (6528): 449–450. Bibcode:2021Sci...371..449C. doi:10.1126/science.371.6528.449. PMID 33510005.
Slaoui, Moncef; Hepburn, Matthew (August 26, 2020). "Developing safe and effective covid vaccines – Operation Warp Speed's strategy and approach". New England Journal of Medicine. 383 (18): 1701–1703. doi:10.1056/nejmp2027405. ISSN 0028-4793. PMID 32846056. S2CID 221347918. advancing eight vaccines in parallel will increase the chances of delivering 300 million doses in the first half of 2021 ... Of the eight vaccines in OWS's portfolio, six have been announced and partnerships executed with the companies: Moderna and Pfizer/BioNTech (both mRNA), AstraZeneca and Janssen (both replication-defective live-vector), and Novavax and Sanofi/GSK (both recombinant-subunit-adjuvanted protein). These candidates progressed to clinical trials.
Diamond, Michael S; Pierson, Theodore C (May 13, 2020). "The challenges of vaccine development against a new virus during a pandemic". Cell Host and Microbe. 27 (5): 699–703. doi:10.1016/j.chom.2020.04.021. PMC 7219397. PMID 32407708.
Kim, Jerome H; Hotez, Peter; Batista, Carolina; Ergonul, Onder; Figueroa, J Peter; Gilbert, Sarah; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Lall, Bhavna; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Shoham, Shmuel; Wilder-Smith, Annelies; Strub-Wourgaft, Nathalie; Yadav, Prashant; Bottazzi, Maria Elena (March 26, 2021). "Operation Warp Speed: implications for global vaccine security". The Lancet Global Health. 9 (7): e1017 – e1021. doi:10.1016/S2214-109X(21)00140-6. ISSN 2214-109X. PMC 7997645. PMID 33780663.
Dubé, Eve; Laberge, Caroline; Guay, Maryse; Bramadat, Paul; Roy, Réal; Bettinger, Julie (August 1, 2013). "Vaccine hesitancy: an overview". Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. ISSN 2164-554X. PMC 3906279. PMID 23584253.

ncbi.nlm.nih.gov

Diamond, Michael S; Pierson, Theodore C (May 13, 2020). "The challenges of vaccine development against a new virus during a pandemic". Cell Host and Microbe. 27 (5): 699–703. doi:10.1016/j.chom.2020.04.021. PMC 7219397. PMID 32407708.
Kim, Jerome H; Hotez, Peter; Batista, Carolina; Ergonul, Onder; Figueroa, J Peter; Gilbert, Sarah; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Lall, Bhavna; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Shoham, Shmuel; Wilder-Smith, Annelies; Strub-Wourgaft, Nathalie; Yadav, Prashant; Bottazzi, Maria Elena (March 26, 2021). "Operation Warp Speed: implications for global vaccine security". The Lancet Global Health. 9 (7): e1017 – e1021. doi:10.1016/S2214-109X(21)00140-6. ISSN 2214-109X. PMC 7997645. PMID 33780663.
Dubé, Eve; Laberge, Caroline; Guay, Maryse; Bramadat, Paul; Roy, Réal; Bettinger, Julie (August 1, 2013). "Vaccine hesitancy: an overview". Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. ISSN 2164-554X. PMC 3906279. PMID 23584253.

nih.gov

RAPID ACCELERATION OF DIAGNOSTICS (RADX)
"Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine". US National Institutes of Health. December 18, 2020. Retrieved March 24, 2020.

novavax.com (Global: low place; English: low place)

ir.novavax.com

"Novavax Announces $1.6 Billion Funding from Operation Warp Speed". Novavax. July 7, 2020. Archived from the original on December 17, 2020. Retrieved December 20, 2020.

npr.org (Global: 92^nd place; English: 72^nd place)

Kennedy, Merrit (January 15, 2021). "Biden Administration Will Rename 'Operation Warp Speed,' Citing Trump 'Failures'". NPR. Archived from the original on January 29, 2021. Retrieved January 29, 2021.

nymag.com (Global: 346^th place; English: 229^th place)

David Wallace-Wells (December 7, 2020). "We had the vaccine the whole time". Intelligencer, New York Magazine, Vox Media Network, Inc. Archived from the original on December 8, 2020. Retrieved December 8, 2020.

nytimes.com (Global: 7^th place; English: 7^th place)

Sanger, David E. (April 29, 2020). "Trump seeks push to speed vaccine, despite safety concerns". The New York Times. Archived from the original on December 9, 2020. Retrieved May 15, 2020.
Kaplan, Sheila (January 15, 2021). "Biden Picks Former F.D.A. Chief to Lead Federal Vaccine Efforts". The New York Times. Archived from the original on January 15, 2021. Retrieved January 15, 2021.
Zraick, Karen (February 24, 2021). "Meet the key members of Biden's Covid-19 response team". The New York Times. ISSN 0362-4331. Retrieved March 7, 2021.
LaFraniere, Sharon; Thomas, Katie; Weiland, Noah; Baker, Peter; Karni, Annie (August 2, 2020). "Scientists Worry About Political Influence Over Coronavirus Vaccine Project". The New York Times. Archived from the original on December 19, 2020. Retrieved December 17, 2020.
Kaplan, Sheila; Stolberg, Sheryl Gay (January 15, 2021). "Biden picks a former F.D.A. chief to lead federal vaccine efforts, which will drop the name Operation Warp Speed". The New York Times. ISSN 0362-4331. Archived from the original on January 27, 2021. Retrieved January 29, 2021.
Katie Thomas (July 7, 2020). "U.S. Will Pay $1.6 Billion to Novavax for Coronavirus Vaccine". The New York Times. Archived from the original on December 17, 2020. Retrieved July 7, 2020.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020. And while the company has said that it is part of Operation Warp Speed – the flagship federal effort to quickly produce treatments and vaccines for the coronavirus – Inovio is not on the list of companies selected to receive financial support to mass-produce vaccines.
Katie Thomas; David Gelles; Carl Zimmer (November 9, 2020). "Pfizer's early data shows vaccine is more than 90% effective". The New York Times. Archived from the original on December 18, 2020. Retrieved November 9, 2020. On Monday, a spokeswoman for Pfizer clarified that the company is part of Operation Warp Speed as a supplier of a potential coronavirus vaccine
"Was the Pfizer vaccine part of the government's Operation Warp Speed?". The New York Times. November 10, 2020. Archived from the original on December 16, 2020. Retrieved November 14, 2020.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020.
Gelles, David; Drucker, Jesse (July 25, 2020). "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine". The New York Times. ISSN 0362-4331. Archived from the original on September 24, 2020. Retrieved September 25, 2020.

pewresearch.org (Global: 1,418^th place; English: 966^th place)

"U.S. Public Now Divided Over Whether To Get COVID-19 Vaccine". Pew Research. September 17, 2020. Archived from the original on October 15, 2020. Retrieved October 15, 2020.

pfizer.com (Global: low place; English: low place)

"Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2" (Press release). Pfizer. July 22, 2020. Retrieved May 25, 2025.

politico.com (Global: 312^th place; English: 197^th place)

Brennan, Zachary (October 2, 2020). "Warp Speed's focus on vaccines may have shortchanged antibody treatments". Politico. Archived from the original on December 8, 2020. Retrieved October 8, 2020.
"Trump misses 20 million Covid shot target". Politico. December 30, 2020. Archived from the original on January 4, 2021. Retrieved January 7, 2021.

politifact.com (Global: 3,208^th place; English: 1,803^rd place)

Victoria Knight (March 5, 2021). "Biden's criticism of Trump administration vaccine contracts too broad to be accurate". PolitiFact. Retrieved February 23, 2025.

prweb.com (Global: 3,093^rd place; English: 1,787^th place)

"Operation Warp Speed Leader Joins ISOA for an Online Discussion on the COVID-19 Vaccine" (Press release). International Stability Operations Association. December 11, 2020. Retrieved July 21, 2021.

reuters.com (Global: 49^th place; English: 47^th place)

Erman, Michael (August 7, 2020). "U.S. to pay $1 billion for 100 million doses of Johnson & Johnson's COVID-19 vaccine candidate". Reuters. Archived from the original on December 12, 2020. Retrieved November 19, 2020.
"BioNTech wins $445 million German grant for COVID-19 vaccine". Reuters. September 15, 2020. Archived from the original on January 25, 2021. Retrieved January 7, 2021.
Carl O'Donnell; Andrea Shalal (February 18, 2021). "Biden to pledge $4 billion to COVAX vaccine program at G7 meeting Friday". Reuters. Retrieved April 1, 2021.

science.org (Global: 1,160^th place; English: 737^th place)

Cohen, Jon (May 12, 2020). "Unveiling 'Warp Speed,' the White House's America-first push for a coronavirus vaccine". Science. doi:10.1126/science.abc7056. S2CID 219432336. Archived from the original on November 29, 2020. Retrieved May 16, 2020.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Cohen, Jon (May 12, 2020). "Unveiling 'Warp Speed,' the White House's America-first push for a coronavirus vaccine". Science. doi:10.1126/science.abc7056. S2CID 219432336. Archived from the original on November 29, 2020. Retrieved May 16, 2020.
Slaoui, Moncef; Hepburn, Matthew (August 26, 2020). "Developing safe and effective covid vaccines – Operation Warp Speed's strategy and approach". New England Journal of Medicine. 383 (18): 1701–1703. doi:10.1056/nejmp2027405. ISSN 0028-4793. PMID 32846056. S2CID 221347918. advancing eight vaccines in parallel will increase the chances of delivering 300 million doses in the first half of 2021 ... Of the eight vaccines in OWS's portfolio, six have been announced and partnerships executed with the companies: Moderna and Pfizer/BioNTech (both mRNA), AstraZeneca and Janssen (both replication-defective live-vector), and Novavax and Sanofi/GSK (both recombinant-subunit-adjuvanted protein). These candidates progressed to clinical trials.

stanford.edu (Global: 179^th place; English: 183^rd place)

securities.stanford.edu

Himmelberg v. Vaxart, Inc. Archived October 11, 2020, at the Wayback Machine, No. 20-cv-05949 (N.D. Cal. August 24, 2020)

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

Matthew Herper; Helen Branswell (January 26, 2021). "In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies". STAT. Archived from the original on February 6, 2021. Retrieved February 5, 2021.

time.com (Global: 61^st place; English: 54^th place)

Emily Barone (December 14, 2020). "The Trump Administration's 'Operation Warp Speed' Has Spent $12.4 Billion on Vaccines. How Much Is That, Really?". Time Magazine. Archived from the original on January 25, 2021. Retrieved January 30, 2021.

usatoday.com (Global: 41^st place; English: 34^th place)

Elizabeth Weise (June 30, 2020). "FDA says a coronavirus vaccine would have to be at least 50% effective to be approved". USA Today. Archived from the original on December 12, 2020. Retrieved July 1, 2020.

washingtonpost.com (Global: 34^th place; English: 27^th place)

How the ‘deep state’ scientists vilified by Trump helped him deliver an unprecedented achievement, Washington Post (December 14, 2020).
McGinley, Laurie (August 11, 2020). "Meet the most important federal official you probably don't know – the man who holds the fate of the coronavirus vaccine in his hands". The Washington Post. Archived from the original on December 14, 2020. Retrieved December 17, 2020.
Nisen, Max (April 30, 2020). "Operation Warp Speed needs to waste money on vaccines". Bloomberg News. The Washington Post. Archived from the original on June 11, 2020. Retrieved May 28, 2020.

wbur.org (Global: 2,911^th place; English: 1,596^th place)

"Baker Says More Communication From Feds Is Key To Smooth Vaccine Distribution". January 5, 2021. Archived from the original on February 14, 2021. Retrieved January 7, 2021.
"Pace Of Coronavirus Vaccination Lags Supply In Mass". January 4, 2021. Archived from the original on January 7, 2021. Retrieved January 7, 2021.

web.archive.org (Global: 1^st place; English: 1^st place)

"Trump Administration Announces Framework and Leadership for 'Operation Warp Speed'". U.S. Department of Health and Human Services. May 15, 2020. Archived from the original on December 16, 2020. Retrieved May 15, 2020. Among its other objectives, Operation Warp Speed aims to have substantial quantities of a safe and effective vaccine available for Americans by January 2021.
"Fact Sheet: Explaining Operation Warp Speed". HHS.gov. US Department of Health and Human Services. November 10, 2020. Archived from the original on December 19, 2020. Retrieved November 24, 2020.
Jacobs, Jennifer; Armstrong, Drew (April 29, 2020). "Trump's 'Operation Warp Speed' aims to rush coronavirus vaccine". Bloomberg News. Archived from the original on December 17, 2020. Retrieved May 15, 2020.
Cohen, Jon (May 12, 2020). "Unveiling 'Warp Speed,' the White House's America-first push for a coronavirus vaccine". Science. doi:10.1126/science.abc7056. S2CID 219432336. Archived from the original on November 29, 2020. Retrieved May 16, 2020.
Sanger, David E. (April 29, 2020). "Trump seeks push to speed vaccine, despite safety concerns". The New York Times. Archived from the original on December 9, 2020. Retrieved May 15, 2020.
Kaplan, Sheila (January 15, 2021). "Biden Picks Former F.D.A. Chief to Lead Federal Vaccine Efforts". The New York Times. Archived from the original on January 15, 2021. Retrieved January 15, 2021.
Jacobs, Jennifer; Armstrong, Drew (April 29, 2020). "Trump's 'Operation Warp Speed' Aims to Rush Coronavirus Vaccine". Bloomberg News. Archived from the original on December 17, 2020. Retrieved May 15, 2020.
LaFraniere, Sharon; Thomas, Katie; Weiland, Noah; Baker, Peter; Karni, Annie (August 2, 2020). "Scientists Worry About Political Influence Over Coronavirus Vaccine Project". The New York Times. Archived from the original on December 19, 2020. Retrieved December 17, 2020.
McGinley, Laurie (August 11, 2020). "Meet the most important federal official you probably don't know – the man who holds the fate of the coronavirus vaccine in his hands". The Washington Post. Archived from the original on December 14, 2020. Retrieved December 17, 2020.
Elizabeth Weise (June 30, 2020). "FDA says a coronavirus vaccine would have to be at least 50% effective to be approved". USA Today. Archived from the original on December 12, 2020. Retrieved July 1, 2020.
Kennedy, Merrit (January 15, 2021). "Biden Administration Will Rename 'Operation Warp Speed,' Citing Trump 'Failures'". NPR. Archived from the original on January 29, 2021. Retrieved January 29, 2021.
Kaplan, Sheila; Stolberg, Sheryl Gay (January 15, 2021). "Biden picks a former F.D.A. chief to lead federal vaccine efforts, which will drop the name Operation Warp Speed". The New York Times. ISSN 0362-4331. Archived from the original on January 27, 2021. Retrieved January 29, 2021.
David Wallace-Wells (December 7, 2020). "We had the vaccine the whole time". Intelligencer, New York Magazine, Vox Media Network, Inc. Archived from the original on December 8, 2020. Retrieved December 8, 2020.
C. Todd Lopez (October 28, 2020). "In Warp Speed Effort, Knowing Where Vaccines Are Is Key to Distribution Strategy". US Department of Defense. Archived from the original on December 5, 2020. Retrieved December 8, 2020.
"AMA, FDA video update: The critical role of health care professionals during COVID-19". AMA-Assn.org. American Medical Association. August 14, 2020. Archived from the original on December 18, 2020. Retrieved December 17, 2020.
Dan Gorenstein (October 30, 2014). "BARDA: The venture capital firm buried in the US government". Marketplace, Minnesota Public Radio. Archived from the original on June 13, 2020. Retrieved November 24, 2020.
Stephanie Baker; Cynthia Koons (October 29, 2020). "Inside Operation Warp Speed's $18 Billion Sprint for a Vaccine". Bloomberg Businessweek. Archived from the original on December 8, 2020. Retrieved November 24, 2020.
Collins, Kaitlan; Diamond, Jeremy; Klein, Betsy (April 22, 2020). "Director of key federal vaccine agency says his departure was retaliation". CNN. Archived from the original on November 1, 2020. Retrieved August 30, 2020.
Crisp, Elizabeth (May 15, 2020). "Trump launches 'operation warp speed' effort to develop coronavirus vaccine by year's end". Newsweek. Archived from the original on May 19, 2020. Retrieved May 15, 2020. The project will cost billions of dollars, one of the people said. And it will almost certainly result in significant waste by making inoculations at scale before knowing if they'll be safe and effective – meaning that vaccines that fail will be useless. But it could mean having doses of vaccine available for the American public by the end of this year, instead of by next summer.
Guckert, Ross (June 4, 2020). "PEO Perspective: June 2020". PEO EIS. Archived from the original on December 20, 2020. Retrieved December 8, 2020.
"LTG Paul Ostrowski, USA (Ret)". National Defense Industrial Association. Archived from the original on December 20, 2020. Retrieved November 27, 2020.
Noah Higgins-Dunn (August 14, 2020). "The U.S. has already invested billions in potential coronavirus vaccines. Here's where the deals stand". CNBC. Archived from the original on December 8, 2020. Retrieved September 24, 2020.
Rivers, Brenda Marie (August 6, 2020). "Johnson & Johnson Secures $1B in Federal Vaccine Production Funding". GovCon Wire. Archived from the original on October 27, 2020. Retrieved November 19, 2020.
"HHS, DOD Collaborate With Johnson & Johnson to Produce Millions of COVID-19 Investigational Vaccine Doses". HHS.gov. August 5, 2020. Archived from the original on December 12, 2020. Retrieved November 19, 2020.
Higgins-Dunn, Noah (August 5, 2020). "Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion". CNBC. Archived from the original on December 9, 2020. Retrieved November 19, 2020.
"Experimental Johnson & Johnson vaccine protects monkeys in a single dose, study finds". CNBC. Reuters. July 30, 2020. Archived from the original on October 25, 2020. Retrieved November 19, 2020.
Erman, Michael (August 7, 2020). "U.S. to pay $1 billion for 100 million doses of Johnson & Johnson's COVID-19 vaccine candidate". Reuters. Archived from the original on December 12, 2020. Retrieved November 19, 2020.
"Trump Administration's Operation Warp Speed Accelerates AstraZeneca COVID-19 Vaccine to be Available Beginning in October". HHS.gov (Press release). May 21, 2020. Archived from the original on December 20, 2020. Retrieved July 22, 2020.
"Vaxart oral COVID-19 vaccine joins Trump's 'Warp Speed,' ramps up manufacturing capacity". Genetic Engineering and Biotechnology News. June 29, 2020. Archived from the original on September 29, 2020. Retrieved July 1, 2020.
Adams, Ben (July 27, 2020). "Moderna nabs a BARDA billion as its kick-starts late-stage pandemic vaccine test". FierceBiotech. Archived from the original on December 9, 2020. Retrieved November 20, 2020.
Katie Thomas (July 7, 2020). "U.S. Will Pay $1.6 Billion to Novavax for Coronavirus Vaccine". The New York Times. Archived from the original on December 17, 2020. Retrieved July 7, 2020.
"HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration Projects". HHS.gov (Press release). July 6, 2020. Archived from the original on December 21, 2020. Retrieved December 20, 2020.
"Novavax Announces $1.6 Billion Funding from Operation Warp Speed". Novavax. July 7, 2020. Archived from the original on December 17, 2020. Retrieved December 20, 2020.
Matthew Herper; Helen Branswell (January 26, 2021). "In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies". STAT. Archived from the original on February 6, 2021. Retrieved February 5, 2021.
Angus Liu (July 31, 2020). "Top vaccine players Sanofi, GSK win $2.1B Warp Speed funding for COVID-19 shot". FiercePharma. Archived from the original on November 28, 2020. Retrieved September 24, 2020.
Hollingsworth, Julia (December 11, 2020). "GlaxoSmithKline and Sanofi Pasteur vaccine delayed until late 2021". CNN. Archived from the original on December 11, 2020. Retrieved December 11, 2020.
"INOVIO Reports Positive Interim Phase I Data for COVID-19 DNA Vaccine, Joins 'Warp Speed' Primate Study". Genetic Engineering and Biotechnology News. June 30, 2020. Archived from the original on October 1, 2020. Retrieved July 1, 2020.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020. And while the company has said that it is part of Operation Warp Speed – the flagship federal effort to quickly produce treatments and vaccines for the coronavirus – Inovio is not on the list of companies selected to receive financial support to mass-produce vaccines.
Brennan, Zachary (October 2, 2020). "Warp Speed's focus on vaccines may have shortchanged antibody treatments". Politico. Archived from the original on December 8, 2020. Retrieved October 8, 2020.
"HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment". HHS.gov (Press release). July 7, 2020. Archived from the original on December 18, 2020. Retrieved October 8, 2020.
"Aiming to address the global coronavirus pandemic: Project Lightspeed". BioNTech. 2020. Archived from the original on December 18, 2020. Retrieved December 13, 2020.
"BioNTech wins $445 million German grant for COVID-19 vaccine". Reuters. September 15, 2020. Archived from the original on January 25, 2021. Retrieved January 7, 2021.
Griffin, Riley; Armstrong, Drew (November 9, 2020). "Pfizer Vaccine's Funding Came From Berlin, Not Washington". Bloomberg News. Archived from the original on November 9, 2020. Retrieved February 8, 2024.
Maxouris, Christina (December 12, 2020). "FDA's Covid-19 vaccine authorization is a 'monumental moment,' expert says. It came on the deadliest day of the pandemic". CNN. Archived from the original on December 17, 2020. Retrieved December 12, 2020.
Axios (November 9, 2020). "Pfizer CEO says he would've released vaccine data before election if possible". Axios. Archived from the original on December 10, 2020. Retrieved November 11, 2020.
Dale, Daniel (November 10, 2020). "Fact-checking the battle for credit over Pfizer's vaccine announcement". CNN. Archived from the original on November 16, 2020. Retrieved February 8, 2024.
Alexander Nazaryan (November 9, 2020). "So is Pfizer part of Operation Warp Speed or not? Yes and no". Yahoo Financial News. Archived from the original on December 11, 2020. Retrieved November 9, 2020.
"U.S. Government Engages Pfizer to Produce Millions of Doses of COVID-19 Vaccine". US Department of Health and Human Services. July 22, 2020. Archived from the original on December 17, 2020. Retrieved July 23, 2020.
Katie Thomas; David Gelles; Carl Zimmer (November 9, 2020). "Pfizer's early data shows vaccine is more than 90% effective". The New York Times. Archived from the original on December 18, 2020. Retrieved November 9, 2020. On Monday, a spokeswoman for Pfizer clarified that the company is part of Operation Warp Speed as a supplier of a potential coronavirus vaccine
"Was the Pfizer vaccine part of the government's Operation Warp Speed?". The New York Times. November 10, 2020. Archived from the original on December 16, 2020. Retrieved November 14, 2020.
Czachor, Emily (November 9, 2020). "Pfizer Avoided R&D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics". Newsweek. Archived from the original on December 9, 2020. Retrieved November 9, 2020.
"Pfizer-BioNTech COVID-19 Vaccine". US Food & Drug Administration (Press release). February 28, 2021. Archived from the original on December 12, 2020. Retrieved March 24, 2021.
"Trump misses 20 million Covid shot target". Politico. December 30, 2020. Archived from the original on January 4, 2021. Retrieved January 7, 2021.
"CDC COVID Data Tracker". March 28, 2020. Archived from the original on January 25, 2021. Retrieved January 6, 2021.
"Operation Warp Speed chief says Covid vaccine distribution 'should be better' as U.S. misses goal". CNBC. December 30, 2020. Archived from the original on January 4, 2021. Retrieved January 7, 2021.
"Baker Says More Communication From Feds Is Key To Smooth Vaccine Distribution". January 5, 2021. Archived from the original on February 14, 2021. Retrieved January 7, 2021.
"Pace Of Coronavirus Vaccination Lags Supply In Mass". January 4, 2021. Archived from the original on January 7, 2021. Retrieved January 7, 2021.
Emily Barone (December 14, 2020). "The Trump Administration's 'Operation Warp Speed' Has Spent $12.4 Billion on Vaccines. How Much Is That, Really?". Time Magazine. Archived from the original on January 25, 2021. Retrieved January 30, 2021.
Jennings, Katie (November 17, 2020). "How Much Will A Covid-19 Vaccine Cost?". Forbes. Archived from the original on December 13, 2020. Retrieved December 6, 2020.
Nisen, Max (April 30, 2020). "Operation Warp Speed needs to waste money on vaccines". Bloomberg News. The Washington Post. Archived from the original on June 11, 2020. Retrieved May 28, 2020.
"FDA Approves First COVID-19 Vaccine". Food and Drug Administration. August 23, 2021. Archived from the original on August 23, 2021. Retrieved May 25, 2025.
McKeever, Vicky (May 21, 2020). "AstraZeneca receives $1 billion in U.S. funding for Oxford University coronavirus vaccine". CNBC. Archived from the original on May 28, 2020. Retrieved May 28, 2020.
Christensen, Jen; Acosta, Jim; Carvajal, Nikki; Vazquez, Maegan (December 8, 2020). "Trump to sign order aimed at prioritizing Covid-19 vaccine shipment to Americans". CNN. Archived from the original on December 8, 2020. Retrieved December 8, 2020.
Trump, Donald. "Executive Order on Ensuring Access to United States Government COVID-19 Vaccines". whitehouse.gov. Archived from the original on January 20, 2021. Retrieved December 12, 2020 – via National Archives.
"Ten health issues WHO will tackle this year". World Health Organization. 2019. Archived from the original on November 11, 2019. Retrieved May 26, 2020.
"U.S. Public Now Divided Over Whether To Get COVID-19 Vaccine". Pew Research. September 17, 2020. Archived from the original on October 15, 2020. Retrieved October 15, 2020.
Kristen Holmes; Sarah Mucha; Gregory Lemos (January 13, 2021). "Head of US vaccine effort resigns at request of incoming Biden administration but will stay through transition". CNN. Archived from the original on February 1, 2021. Retrieved January 30, 2021.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020.
Himmelberg v. Vaxart, Inc. Archived October 11, 2020, at the Wayback Machine, No. 20-cv-05949 (N.D. Cal. August 24, 2020)
Gelles, David; Drucker, Jesse (July 25, 2020). "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine". The New York Times. ISSN 0362-4331. Archived from the original on September 24, 2020. Retrieved September 25, 2020.

who.int (Global: 195^th place; English: 302^nd place)

"Ten health issues WHO will tackle this year". World Health Organization. 2019. Archived from the original on November 11, 2019. Retrieved May 26, 2020.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Zraick, Karen (February 24, 2021). "Meet the key members of Biden's Covid-19 response team". The New York Times. ISSN 0362-4331. Retrieved March 7, 2021.
Kaplan, Sheila; Stolberg, Sheryl Gay (January 15, 2021). "Biden picks a former F.D.A. chief to lead federal vaccine efforts, which will drop the name Operation Warp Speed". The New York Times. ISSN 0362-4331. Archived from the original on January 27, 2021. Retrieved January 29, 2021.
Borrell, Brendan Jonathan (2021). The first shots: the epic rivalries and heroic science behind the race to the coronavirus vaccine. New York: Mariner Books. pp. 139–143. ISBN 978-0-358-56984-8. OCLC 1275436164.
Slaoui, Moncef; Hepburn, Matthew (August 26, 2020). "Developing safe and effective covid vaccines – Operation Warp Speed's strategy and approach". New England Journal of Medicine. 383 (18): 1701–1703. doi:10.1056/nejmp2027405. ISSN 0028-4793. PMID 32846056. S2CID 221347918. advancing eight vaccines in parallel will increase the chances of delivering 300 million doses in the first half of 2021 ... Of the eight vaccines in OWS's portfolio, six have been announced and partnerships executed with the companies: Moderna and Pfizer/BioNTech (both mRNA), AstraZeneca and Janssen (both replication-defective live-vector), and Novavax and Sanofi/GSK (both recombinant-subunit-adjuvanted protein). These candidates progressed to clinical trials.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020. And while the company has said that it is part of Operation Warp Speed – the flagship federal effort to quickly produce treatments and vaccines for the coronavirus – Inovio is not on the list of companies selected to receive financial support to mass-produce vaccines.
Kim, Jerome H; Hotez, Peter; Batista, Carolina; Ergonul, Onder; Figueroa, J Peter; Gilbert, Sarah; Gursel, Mayda; Hassanain, Mazen; Kang, Gagandeep; Lall, Bhavna; Larson, Heidi; Naniche, Denise; Sheahan, Timothy; Shoham, Shmuel; Wilder-Smith, Annelies; Strub-Wourgaft, Nathalie; Yadav, Prashant; Bottazzi, Maria Elena (March 26, 2021). "Operation Warp Speed: implications for global vaccine security". The Lancet Global Health. 9 (7): e1017 – e1021. doi:10.1016/S2214-109X(21)00140-6. ISSN 2214-109X. PMC 7997645. PMID 33780663.
Dubé, Eve; Laberge, Caroline; Guay, Maryse; Bramadat, Paul; Roy, Réal; Bettinger, Julie (August 1, 2013). "Vaccine hesitancy: an overview". Human Vaccines & Immunotherapeutics. 9 (8): 1763–1773. doi:10.4161/hv.24657. ISSN 2164-554X. PMC 3906279. PMID 23584253.
Gelles, David; Murphy, Heather (August 11, 2020). "This Company Boasted to Trump About Its Covid-19 Vaccine. Experts Are Skeptical". The New York Times. ISSN 0362-4331. Archived from the original on November 25, 2020. Retrieved September 25, 2020.
Gelles, David; Drucker, Jesse (July 25, 2020). "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine". The New York Times. ISSN 0362-4331. Archived from the original on September 24, 2020. Retrieved September 25, 2020.

yahoo.com (Global: 38^th place; English: 40^th place)

ca.news.yahoo.com

Alexander Nazaryan (November 9, 2020). "So is Pfizer part of Operation Warp Speed or not? Yes and no". Yahoo Financial News. Archived from the original on December 11, 2020. Retrieved November 9, 2020.

Operation Warp Speed (English Wikipedia)

ama-assn.org (Global: 3,257th place; English: 3,398th place)

archive.today (Global: 14th place; English: 14th place)

archives.gov (Global: 446th place; English: 308th place)

trumpwhitehouse.archives.gov

army.mil (Global: 249th place; English: 169th place)

eis.army.mil

axios.com (Global: 1,716th place; English: 973rd place)

bbc.co.uk (Global: 8th place; English: 10th place)

biontech.de (Global: low place; English: low place)

biontech.de

investors.biontech.de

bloomberg.com (Global: 99th place; English: 77th place)

cdc.gov (Global: 218th place; English: 212th place)

cdc.gov

covid.cdc.gov

cnbc.com (Global: 220th place; English: 155th place)

cnn.com (Global: 28th place; English: 26th place)

edition.cnn.com

cnn.com

defense.gov (Global: 1,038th place; English: 668th place)

digitech-insight.com (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

esquire.com (Global: 472nd place; English: 340th place)

fda.gov (Global: 447th place; English: 338th place)

fiercebiotech.com (Global: low place; English: 8,828th place)

fiercepharma.com (Global: low place; English: 8,921st place)

forbes.com (Global: 54th place; English: 48th place)

gao.gov (Global: 2,954th place; English: 1,848th place)

genengnews.com (Global: low place; English: 6,625th place)

govconwire.com (Global: low place; English: low place)

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

hhs.gov (Global: 5,973rd place; English: 3,693rd place)

marketplace.org (Global: low place; English: 6,795th place)

medcitynews.com (Global: low place; English: low place)

nbcnews.com (Global: 137th place; English: 101st place)

ndia.org (Global: low place; English: low place)

newsweek.com (Global: 269th place; English: 201st place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nih.gov

novavax.com (Global: low place; English: low place)

ir.novavax.com

npr.org (Global: 92nd place; English: 72nd place)

nymag.com (Global: 346th place; English: 229th place)

nytimes.com (Global: 7th place; English: 7th place)

pewresearch.org (Global: 1,418th place; English: 966th place)

pfizer.com (Global: low place; English: low place)

politico.com (Global: 312th place; English: 197th place)

politifact.com (Global: 3,208th place; English: 1,803rd place)

prweb.com (Global: 3,093rd place; English: 1,787th place)

reuters.com (Global: 49th place; English: 47th place)

science.org (Global: 1,160th place; English: 737th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

stanford.edu (Global: 179th place; English: 183rd place)

securities.stanford.edu

statnews.com (Global: 8,771st place; English: 5,253rd place)

time.com (Global: 61st place; English: 54th place)

usatoday.com (Global: 41st place; English: 34th place)

washingtonpost.com (Global: 34th place; English: 27th place)

wbur.org (Global: 2,911th place; English: 1,596th place)

web.archive.org (Global: 1st place; English: 1st place)

who.int (Global: 195th place; English: 302nd place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

yahoo.com (Global: 38th place; English: 40th place)

ca.news.yahoo.com

ama-assn.org (Global: 3,257^th place; English: 3,398^th place)

archive.today (Global: 14^th place; English: 14^th place)

archives.gov (Global: 446^th place; English: 308^th place)

army.mil (Global: 249^th place; English: 169^th place)

axios.com (Global: 1,716^th place; English: 973^rd place)

bbc.co.uk (Global: 8^th place; English: 10^th place)

bloomberg.com (Global: 99^th place; English: 77^th place)

cdc.gov (Global: 218^th place; English: 212^th place)

cnbc.com (Global: 220^th place; English: 155^th place)

cnn.com (Global: 28^th place; English: 26^th place)

defense.gov (Global: 1,038^th place; English: 668^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

esquire.com (Global: 472^nd place; English: 340^th place)

fda.gov (Global: 447^th place; English: 338^th place)

fiercebiotech.com (Global: low place; English: 8,828^th place)

fiercepharma.com (Global: low place; English: 8,921^st place)

forbes.com (Global: 54^th place; English: 48^th place)

gao.gov (Global: 2,954^th place; English: 1,848^th place)

genengnews.com (Global: low place; English: 6,625^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

hhs.gov (Global: 5,973^rd place; English: 3,693^rd place)

marketplace.org (Global: low place; English: 6,795^th place)

nbcnews.com (Global: 137^th place; English: 101^st place)

newsweek.com (Global: 269^th place; English: 201^st place)

nih.gov (Global: 4^th place; English: 4^th place)

npr.org (Global: 92^nd place; English: 72^nd place)

nymag.com (Global: 346^th place; English: 229^th place)

nytimes.com (Global: 7^th place; English: 7^th place)

pewresearch.org (Global: 1,418^th place; English: 966^th place)

politico.com (Global: 312^th place; English: 197^th place)

politifact.com (Global: 3,208^th place; English: 1,803^rd place)

prweb.com (Global: 3,093^rd place; English: 1,787^th place)

reuters.com (Global: 49^th place; English: 47^th place)

science.org (Global: 1,160^th place; English: 737^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

stanford.edu (Global: 179^th place; English: 183^rd place)

statnews.com (Global: 8,771^st place; English: 5,253^rd place)

time.com (Global: 61^st place; English: 54^th place)

usatoday.com (Global: 41^st place; English: 34^th place)

washingtonpost.com (Global: 34^th place; English: 27^th place)

wbur.org (Global: 2,911^th place; English: 1,596^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

who.int (Global: 195^th place; English: 302^nd place)

worldcat.org (Global: 5^th place; English: 5^th place)

yahoo.com (Global: 38^th place; English: 40^th place)